• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人惰性系统性肥大细胞疾病:骨髓肥大细胞的免疫表型特征及其诊断意义。

Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications.

作者信息

Escribano L, Orfao A, Díaz-Agustin B, Villarrubia J, Cerveró C, López A, Marcos M A, Bellas C, Fernández-Cañadas S, Cuevas M, Sánchez A, Velasco J L, Navarro J L, Miguel J F

机构信息

Servicio de Hematología, Anatomía Patológica, Dermatología, and Inmunología, Hospital Ramón y Cajal, Universidad de Alcalá de Henares, Madrid, Spain.

出版信息

Blood. 1998 Apr 15;91(8):2731-6.

PMID:9531582
Abstract

The aim of the present study was to explore the diagnostic value of the immunophenotypic analysis of bone marrow mast cells (BMMC) in indolent systemic mast cell disease (SMCD) patients. For that purpose, a total of 10 SMCD patients and 19 healthy controls were analyzed. Our results show that BMMC from SMCD are different from normal BMMC with regard to both their light scatter and immunophenotypic characteristics. Accordingly, forward light scatter (FSC), side (90 degrees) light scatter (SSC), and baseline autofluorescence levels were higher in BMMC from indolent SMCD patients than they were in control subjects. From the immunophenotypic point of view, the most striking findings were the constant expression of CD2 (P = .0001), CD25 (P = .0001), and CD35 (P = .06) molecules by BMMC from SMCD patients, markers that were absent from all normal controls. In contrast, CD71, absent in BMMC from indolent SMCD, was positive in BMMC from normal subjects. Although, slight differences between BMMC from SMCD patients and normal controls were found in several other markers, they did not reach statistical significance. In conclusion, our results show that simultaneous assessment of FSC/SSC and reactivity for the CD117, CD2, CD25, CD33, and CD35 forms the basis for the immunophenotypic characterization of BMMC from SMCD in adults and should be integrated with clinical and morphologic studies for the diagnosis of the disease.

摘要

本研究的目的是探讨骨髓肥大细胞(BMMC)免疫表型分析在惰性系统性肥大细胞病(SMCD)患者中的诊断价值。为此,共分析了10例SMCD患者和19例健康对照。我们的结果表明,SMCD患者的BMMC在光散射和免疫表型特征方面均与正常BMMC不同。因此,惰性SMCD患者的BMMC前向光散射(FSC)、侧向(90度)光散射(SSC)和基线自发荧光水平均高于对照受试者。从免疫表型角度来看,最显著的发现是SMCD患者的BMMC持续表达CD2(P = .0001)、CD25(P = .0001)和CD35(P = .06)分子,而所有正常对照均无这些标志物。相反,惰性SMCD患者的BMMC中不存在的CD71在正常受试者的BMMC中呈阳性。虽然在其他几个标志物中发现SMCD患者的BMMC与正常对照之间存在细微差异,但未达到统计学意义。总之,我们的结果表明,同时评估FSC/SSC以及CD117、CD2、CD25、CD33和CD35的反应性构成了成人SMCD患者BMMC免疫表型特征的基础,并且应该与临床和形态学研究相结合用于疾病的诊断。

相似文献

1
Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications.成人惰性系统性肥大细胞疾病:骨髓肥大细胞的免疫表型特征及其诊断意义。
Blood. 1998 Apr 15;91(8):2731-6.
2
Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults.成人惰性系统性肥大细胞病中骨髓肥大细胞的免疫表型
Leuk Lymphoma. 1999 Oct;35(3-4):227-35. doi: 10.3109/10428199909145725.
3
Indolent systemic mast cell disease: immunophenotypic characterization of bone marrow mast cells by flow cytometry.惰性系统性肥大细胞疾病:通过流式细胞术对骨髓肥大细胞进行免疫表型特征分析
J Eur Acad Dermatol Venereol. 2003 Mar;17(2):160-6. doi: 10.1046/j.1468-3083.2003.00603.x.
4
Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia.一例系统性肥大细胞疾病演变为肥大细胞白血病过程中肥大细胞的序贯免疫表型分析
Cytometry. 1997 Apr 15;30(2):98-102. doi: 10.1002/(sici)1097-0320(19970415)30:2<98::aid-cyto4>3.0.co;2-9.
5
Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis.系统性肥大细胞增多症患者骨髓肥大细胞表面补体受体及相关抗原的过表达。
Br J Haematol. 2003 Jan;120(2):257-65. doi: 10.1046/j.1365-2141.2003.04055.x.
6
Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients.成人肥大细胞疾病患者的骨髓肥大细胞免疫表型分析:33例患者的前瞻性研究
Leuk Res. 2004 Aug;28(8):777-83. doi: 10.1016/j.leukres.2003.10.035.
7
Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.肥大细胞的流式细胞术分析在成人肥大细胞增多症诊断和分类中的应用
Leuk Res. 2001 Jul;25(7):563-70. doi: 10.1016/s0145-2126(01)00050-9.
8
The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease.CD69早期激活分子在患有惰性系统性肥大细胞疾病的成年人类骨髓肥大细胞中过度表达。
Br J Haematol. 1999 Aug;106(2):400-5. doi: 10.1046/j.1365-2141.1999.01572.x.
9
Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples.人骨髓肥大细胞的免疫表型特征。正常和病理骨髓样本的流式细胞术研究。
Anal Cell Pathol. 1998;16(3):151-9. doi: 10.1155/1998/341340.
10
Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia.人骨髓肥大细胞中Bcl-2的表达及其在肥大细胞白血病中的过表达。
Am J Hematol. 1999 Mar;60(3):191-5. doi: 10.1002/(sici)1096-8652(199903)60:3<191::aid-ajh4>3.0.co;2-y.

引用本文的文献

1
Mastocytosis.肥大细胞增多症
Nat Rev Dis Primers. 2025 Apr 24;11(1):30. doi: 10.1038/s41572-025-00611-8.
2
Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis.系统性肥大细胞增多症中肥大细胞上CD2、CD25和/或CD30表达的预后影响:欧洲肥大细胞增多症能力网络的一项注册研究
Leukemia. 2025 Mar;39(3):675-683. doi: 10.1038/s41375-024-02504-3. Epub 2025 Jan 15.
3
Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts.
针对晚期肥大细胞增多症的抗体和细胞治疗:既定和新的概念。
Int J Mol Sci. 2023 Oct 12;24(20):15125. doi: 10.3390/ijms242015125.
4
Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation.分泌型和膜相关生物标志物在肥大细胞激活和增殖中的作用。
Int J Mol Sci. 2023 Apr 11;24(8):7071. doi: 10.3390/ijms24087071.
5
Challenges in applying diagnostic criteria for systemic mastocytosis.系统性肥大细胞增多症诊断标准应用中的挑战。
Blood Adv. 2023 Jul 11;7(13):3150-3154. doi: 10.1182/bloodadvances.2023009826.
6
Comprehensive mastocytosis data analysis from a single center.来自单一中心的全面肥大细胞增多症数据分析。
BMC Cancer. 2023 Jan 24;23(1):82. doi: 10.1186/s12885-022-10498-3.
7
Acute Mast Cell Leukemia Preceded by Malignant Mediastinal Germ Cell Tumor: A Case Report and Literature Review.恶性纵隔生殖细胞肿瘤继发急性肥大细胞白血病:一例报告及文献复习
Cancer Manag Res. 2022 May 23;14:1783-1794. doi: 10.2147/CMAR.S363508. eCollection 2022.
8
Expression of CD38 in Mast Cells: Cytological and Histotopographic Features.肥大细胞中 CD38 的表达:细胞学和组织形态学特征。
Cells. 2021 Sep 22;10(10):2511. doi: 10.3390/cells10102511.
9
Increased Copy Number in a Family With Elevated Basal Serum Levels of Tryptase.一个基础血清类胰蛋白酶水平升高的家族中拷贝数增加
Front Med (Lausanne). 2021 Apr 13;8:577081. doi: 10.3389/fmed.2021.577081. eCollection 2021.
10
B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients.治疗的多发性骨髓瘤患者骨髓中的B细胞再生情况及微小残留病状态
Cancers (Basel). 2021 Apr 3;13(7):1704. doi: 10.3390/cancers13071704.